| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/27/2008 | CN101250119A Dinaphthol derivatives as well as preparation method and uses thereof |
| 08/27/2008 | CN101249262A Targeted nano granule of humanization monoclonal antibody trastuzumab modified packaged toxin protein, and preparation and applications thereof |
| 08/27/2008 | CN101249245A Medicament for curing esophagus cancer and cardiac cancer |
| 08/27/2008 | CN101249243A Chinese medicine for curing acute leukemia |
| 08/27/2008 | CN101249235A Chinese medicine for curing esophagus cancer and method of preparing the same |
| 08/27/2008 | CN101249201A Medicament for curing lymph knubble and other malignant tumor and method of preparing the same |
| 08/27/2008 | CN101249133A Medicament for treating leukemia and manufacturing method |
| 08/27/2008 | CN101249089A Applications of isobavachin for preparing antineoplastic, osteoporosis and senile dementia medicament |
| 08/27/2008 | CN101249088A Applications of compensating bone fat flavanone methyl ether for preparing antineoplastic, osteoporosis and senile dementia medicamentË |
| 08/27/2008 | CN101249087A Applications of isobavachin for preparing antineoplastic, osteoporosis and senile dementia medicament |
| 08/27/2008 | CN101249082A Preparation of acidum citricum tamoxifen polylactic acid-glycolic co-polymer microballoons |
| 08/27/2008 | CN101249075A Preparation of water-soluble hypocrellin earth silicon nano granule based on hypocrellin nano crystal |
| 08/27/2008 | CN101249071A Preparation of 2-methoxyl group estradiol vena nano emulsions |
| 08/27/2008 | CN101249070A 2-methoxy estradiol vena nano emulsions |
| 08/27/2008 | CN101249069A Tilmicosin long-acting injection and method of preparing the same |
| 08/27/2008 | CN101249067A Anticancer sustained-release injection containing tumour medicament-resistant reverse agent and cell toxicity medicament |
| 08/27/2008 | CN101249066A Sustained-release agent containing hormone anti-cancer medicine |
| 08/27/2008 | CN101249063A Calciparine/sodium salt nano oral preparation and preparation technique thereof |
| 08/27/2008 | CN100413961C Inhibition of nuclear transcription factor NF- kappa B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
| 08/27/2008 | CN100413883C Peptidic compounds selectively binding to p-selectin |
| 08/27/2008 | CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/27/2008 | CN100413874C Novel water soluble Pt (II) anti-cancer ligand and its preparing method |
| 08/27/2008 | CN100413868C Compounds separated from gamboges with activities of inhibiting tumour/cancer cell growth and pharmaceutical compositions containing same |
| 08/27/2008 | CN100413867C 4-amino-5-phenyl-7-cyclohexyl-pyrrolo[2,3-d]pyrimidine derivatives |
| 08/27/2008 | CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same |
| 08/27/2008 | CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same |
| 08/27/2008 | CN100413845C Compounds for modulating cell proliferation |
| 08/27/2008 | CN100413510C Mannosan peptide injection and preparation method thereof |
| 08/27/2008 | CN100413509C Use of lambda-carrageenan oligose in preparing blood vessel proliferation inhibitor |
| 08/27/2008 | CN100413508C Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 08/27/2008 | CN100413493C Use of gossypol and its derivative in preparation of drug for leukemia / bone marrow cancer |
| 08/26/2008 | US7417137 Tissue specific promoter for expression of a nucleic acid in a cancer cell, where expression is carcinoma selective; useful for tumor-selective suicide gene therapy |
| 08/26/2008 | US7417113 Antitumor agents; anticancer agents; antibody binding |
| 08/26/2008 | US7417110 Biocompatability; polyphosphoester/polyphosphoramidate linkages; improved gene delivery into muscles; DNA vaccines |
| 08/26/2008 | US7417058 Reacting cyanophenyl-4-sulfonylchloride with a piperidine-4-oxo in presence of ethylene glycol to form an intermediate, reducing cyano group, followed by amidation, then reacting with an amine to form sulfonamide end |
| 08/26/2008 | US7417041 Imidazopyrimidines as transforming growth factor (TGF) inhibitors |
| 08/26/2008 | US7417038 administering to the patient an effective amount of an agent which reduces sympathetic nervous system activity; a beta receptor blocker or a compound which inhibits the effect of aldosterone |
| 08/26/2008 | US7417034 Pharmaceutically active uridine esters |
| 08/26/2008 | US7417033 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 08/26/2008 | US7417023 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 08/26/2008 | US7416885 Proliferation factor is obtained from the UCHT1 rat thyroid cell line, or a fragment, analogue or derivateve |
| 08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 08/26/2008 | US7416848 DNA encoding SNORF25 receptor |
| 08/26/2008 | US7416846 A vaccine composition comprising virus-like particles (VLPs) containing L1 proteins or functional L1 protein derivatives from human papillomavirus (HPV) 16, HPV 18, HPV 31 and HPV 45 genotypes and an adjuvant;anticarcinogenic agents; antumor agents; viricides |
| 08/26/2008 | US7416730 Derivatives of the IL-2 receptor gamma chain, their production and use |
| 08/26/2008 | US7416726 Cytotoxicity; therapeutic antibody |
| 08/26/2008 | US7416724 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2400007C Immunization of an individual against carcinoma and the preliminary stages thereof |
| 08/26/2008 | CA2397961C Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors |
| 08/26/2008 | CA2392165C Vitamin d analogues |
| 08/26/2008 | CA2347474C Bicyclic nitrogen heterocycles |
| 08/26/2008 | CA2333669C 17.beta.-amino and hydroxylamino-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 08/26/2008 | CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase |
| 08/26/2008 | CA2208981C Novel trienoic retinoid compounds and methods |
| 08/21/2008 | WO2008101214A2 Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders |
| 08/21/2008 | WO2008101195A2 Drug resistance reversal in neoplastic disease |
| 08/21/2008 | WO2008101118A2 A gene expression signature identifying pro-angiogenic genes in ovarian tumor endothelial cell isolates |
| 08/21/2008 | WO2008101087A1 Compositions and methods for modulation of pdx-1 |
| 08/21/2008 | WO2008100995A1 Humanized anti-cd100 antibodies |
| 08/21/2008 | WO2008100985A2 Combination of lbh589 with other therapeutic agents for treating cancer |
| 08/21/2008 | WO2008100913A2 Early detection and prognosis of colon cancers |
| 08/21/2008 | WO2008100805A2 Anti-robo4 antibodies and uses therefor |
| 08/21/2008 | WO2008100628A2 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases |
| 08/21/2008 | WO2008100622A2 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | WO2008100620A2 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | WO2008100618A2 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 08/21/2008 | WO2008100598A2 A method for enhancing t cell response |
| 08/21/2008 | WO2008100560A2 Estrogen receptor modulators, associated pharmaceutical compositions and methods of use |
| 08/21/2008 | WO2008100448A2 Method of treating cell proliferative disorders using growth hormone secretagogues |
| 08/21/2008 | WO2008100384A2 Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
| 08/21/2008 | WO2008099944A1 Crystalline forms of thiazolidinedione derivative and its manufacturing method |
| 08/21/2008 | WO2008099928A1 Placental protein having action of regulating protease activity and its related gene |
| 08/21/2008 | WO2008099908A1 Vaccine therapy for choroidal neovascularization |
| 08/21/2008 | WO2008099883A1 Therapeutic agent for liver cancer |
| 08/21/2008 | WO2008099414A1 NOVEL CATIONIC 17 α- SUBSTITUTED-ESTRADIOL DERIVATIVES USEFUL AS ANTI-CANCER AGENT |
| 08/21/2008 | WO2008099144A2 Tgf-beta stimulant and further agent to reduce side effects |
| 08/21/2008 | WO2008099088A2 Method for the in vitro culture of t cells, in particular t cells infiltrating the so-called til tumours |
| 08/21/2008 | WO2008099075A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors |
| 08/21/2008 | WO2008099074A1 Phenyl- (4-phenyl-pyrimidin-2-yl) - amine derivatives as ikk inhibitors, preparation thereof, and pharmaceutical compositions thereof |
| 08/21/2008 | WO2008099073A1 N, n' -2, 4-dianilinopyrimidines preparation and use thereof as ikk inhibitors preparation and teh pharmacuetical compositions thereof |
| 08/21/2008 | WO2008099001A1 Use of a leukocyte diminishing or inactivating agent in combination with bacterially-mediated tumor treatment |
| 08/21/2008 | WO2008098970A1 Anhydrous crystalline vinflunine salts, method of preparation and use thereof as a drug and means of vinflunine purification |
| 08/21/2008 | WO2008098789A2 Dual acting prodrugs |
| 08/21/2008 | WO2008098701A1 Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives |
| 08/21/2008 | WO2008098485A1 The salts of 4-aniline quinazoline derivative |
| 08/21/2008 | WO2008098415A1 Pharmaceutical composition containing taxane and its preparation process and application |
| 08/21/2008 | WO2008098379A1 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 08/21/2008 | WO2008098375A1 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
| 08/21/2008 | WO2008098351A1 Treatment of d-cyclin mediated proliferative diseases and hemotological malignancies |
| 08/21/2008 | WO2008098308A1 Agents and methods for treatment of cell proliferative diseases and conditions |
| 08/21/2008 | WO2008098304A1 Carborane-phosphonium compounds and their use in boron neutron capture therapy and imaging |
| 08/21/2008 | WO2008080134A3 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors |
| 08/21/2008 | WO2008075349B1 Therapeutic methods using a thymus peptide |
| 08/21/2008 | WO2008069922A9 Compositions including triciribine and anthracyclin analogs and methods of use thereof |
| 08/21/2008 | WO2008060932A3 Methods for improved engraftment following stem cell transplantation |
| 08/21/2008 | WO2008060581A3 Compositions including triciribine and trastuzumab and methods of use thereof |
| 08/21/2008 | WO2008057291B1 Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof |